SPCC569.07 Antibody

What is the SPCC569.07 protein and why develop antibodies against it?

SPCC569.07 is a protein expressed in S. pombe that plays a role in cellular functions related to protein glycosylation pathways. Antibodies against this protein are valuable tools for investigating protein localization, expression levels, and functional characterization. The protein shares structural similarities with other cell wall-associated proteins identified in fission yeast, particularly those involved in stress responses and cell wall integrity . Developing specific antibodies enables researchers to track this protein through various cellular processes and under different experimental conditions.

What types of SPCC569.07 antibodies are available for research?

While commercial availability of specific SPCC569.07 antibodies may be limited, researchers typically employ several types for different applications:

For detecting GFP-tagged SPCC569.07, polyclonal anti-GFP antibodies have been successfully used in Western blot analyses, as demonstrated in similar experimental setups with S. pombe proteins .

What controls should I include when using SPCC569.07 antibodies?

Proper experimental controls are crucial for validating SPCC569.07 antibody specificity and performance:

• Negative controls: Include samples from SPCC569.07 deletion strains to confirm antibody specificity.

• Positive controls: Use purified recombinant SPCC569.07 protein or overexpression strains.

• Cross-reactivity controls: Test the antibody against closely related proteins to assess specificity.

• Secondary antibody-only controls: Verify that secondary antibodies don't produce non-specific signals.

• Loading controls: Include detection of housekeeping proteins (like tubulin) to normalize expression levels.

For GFP-tagged constructs, comparing anti-GFP antibody signals with direct GFP fluorescence can provide additional validation of antibody specificity and protein localization .

How should I optimize Western blot conditions for SPCC569.07 detection?

Optimizing Western blot conditions for SPCC569.07 detection requires careful consideration of several parameters:

• Sample preparation: Yeast cells require efficient lysis methods, typically using glass beads or enzymatic digestion followed by detergent treatment. Include protease inhibitors to prevent protein degradation.

• Protein denaturation conditions: Test both reduced and non-reduced conditions, as antibody reactivity may depend on protein folding state. Similar to observations with other antibodies (like MA1-18066), SPCC569.07 antibodies might react differently with denatured, non-reduced versus denatured, reduced forms of the protein .

• Gel percentage and transfer conditions:

  • For proteins 25-30 kDa: 12-15% acrylamide gels

  • For larger proteins or fusion constructs: 8-10% acrylamide gels

  • Transfer time: 60-90 minutes at 100V for standard proteins

• Blocking conditions: 5% non-fat dry milk or BSA in TBST, incubating for 1 hour at room temperature.

• Antibody dilutions: Start with 1:1000 for primary antibody and 1:5000 for secondary antibody, then optimize as needed.

• Detection system: ECL-based chemiluminescence for standard applications, or fluorescent secondary antibodies for quantitative analysis.

How can I use SPCC569.07 antibodies to study protein-protein interactions?

SPCC569.07 antibodies can be powerful tools for investigating protein-protein interactions through several complementary approaches:

• Co-immunoprecipitation (Co-IP):

  • Use SPCC569.07 antibodies coupled to protein A/G beads to precipitate the protein complex

  • Analyze co-precipitated proteins by mass spectrometry or Western blotting

  • Include appropriate controls (pre-immune serum, IgG controls)

  • For quantitative analysis, compare precipitation efficiency under different conditions

• Proximity ligation assay (PLA):

  • Combine SPCC569.07 antibodies with antibodies against suspected interaction partners

  • Secondary antibodies linked to complementary DNA oligonucleotides generate signals when proteins are in close proximity

  • This technique allows in situ visualization of protein interactions with high sensitivity

• Bimolecular fluorescence complementation (BiFC) validation:

  • While not directly using antibodies, this technique can validate interactions detected by antibody-based methods

  • Engineer fusion proteins with split fluorescent protein fragments

  • Reconstitution of fluorescence indicates protein interaction

For yeast proteins like SPCC569.07, crosslinking prior to immunoprecipitation may help capture transient interactions that occur during dynamic cellular processes like cell wall formation or septum assembly .

What are the best methods for using SPCC569.07 antibodies in immunolocalization studies?

For successful immunolocalization of SPCC569.07 in S. pombe, consider these optimized protocols:

• Fixation methods:

  • For standard microscopy: 4% formaldehyde fixation for 30 minutes

  • For preserving membrane structures: Combined formaldehyde-zinc fixation similar to techniques used for sperm protein analysis

  • For electron microscopy: Glutaraldehyde-based fixation

• Cell wall digestion:

  • Critical for antibody penetration in yeast cells

  • Use zymolyase or lysing enzymes to partially digest the cell wall

  • Monitor digestion microscopically to avoid over-digestion and cell lysis

• Permeabilization:

  • 0.1% Triton X-100 or 0.5% NP-40 for 10 minutes at room temperature

  • Assess multiple detergents as they affect different cellular compartments

• Antibody dilutions and incubation:

  • Primary antibody: 1:50 to 1:200, overnight at 4°C

  • Secondary antibody: 1:500 to 1:1000, 1-2 hours at room temperature

  • Include DAPI staining for nuclear visualization

• Advanced imaging techniques:

  • Super-resolution microscopy (SIM, STORM) for precise localization

  • Time-lapse imaging of GFP-tagged proteins with antibody validation in fixed timepoints

  • Correlative light-electron microscopy for ultrastructural context

For proteins with potential cell wall or membrane associations like SPCC569.07, compare multiple fixation methods, as protein epitope accessibility can be significantly affected by crosslinking reagents .

How can I troubleshoot weak or non-specific signals when using SPCC569.07 antibodies?

When encountering signal issues with SPCC569.07 antibodies, implement this systematic troubleshooting approach:

• Weak or absent signal:

  • Increase protein loading (20-50 μg total protein per lane)

  • Reduce antibody dilution (more concentrated)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use signal enhancement systems (biotin-streptavidin amplification)

  • Test alternative epitope retrieval methods for fixed samples

  • Verify protein expression timing and conditions

• High background or non-specific binding:

  • Increase blocking time and concentration (5% BSA or milk, 2 hours)

  • Add 0.1-0.5% Tween-20 to washing buffers

  • Pre-absorb antibodies with cell lysates from knockout strains

  • Test multiple secondary antibodies to find optimal specificity

  • Increase washing steps (5 washes, 10 minutes each)

  • Use highly purified antibody fractions

• Sample preparation issues:

  • Ensure complete protease inhibition during extraction

  • Test multiple lysis buffers (RIPA, NP-40, Triton X-100)

  • For cell fractionation studies, verify fraction purity with compartment-specific markers

  • Consider native versus denaturing conditions based on epitope accessibility

• Cross-reactivity assessment:

  • Perform peptide competition assays to verify specificity

  • Test antibody against lysates from deletion strains

  • Check for reactivity with closely related proteins using sequence alignment and recombinant proteins

Similar to antibodies for other cell wall proteins, SPCC569.07 antibodies may show different reactivity depending on whether the protein is denatured and reduced or non-reduced .

How can I use SPCC569.07 antibodies to study protein modifications during cell cycle progression?

SPCC569.07 protein modifications throughout the cell cycle can be investigated using these specialized approaches:

• Cell synchronization and sampling:

  • Synchronize S. pombe cultures using cdc25-22 temperature shift, hydroxyurea block, or lactose gradient centrifugation

  • Collect samples at defined timepoints (G1, S, G2, M phases)

  • Verify synchronization efficiency with flow cytometry or septation index quantification

• Phosphorylation analysis:

  • Use Phos-tag gels to separate phosphorylated species

  • Perform phosphatase treatments prior to immunoblotting

  • Use phospho-specific antibodies if phosphorylation sites are known

• Glycosylation assessment:

  • Treat samples with endoglycosidases (EndoH, PNGase F)

  • Compare mobility shifts before and after treatment

  • Given S. pombe's protein glycosylation machinery described in the literature , this may be particularly relevant for SPCC569.07

• Stability and turnover:

  • Cycloheximide chase experiments with antibody detection at various timepoints

  • Proteasome inhibitor treatment to assess degradation pathways

  • Correlation with cell cycle phases using synchronized cultures

• Quantitative analysis:

  • Use fluorescent secondary antibodies for precise quantification

  • Normalize to unchanging control proteins

  • Plot relative abundance against cell cycle progression markers

Since SPCC569.07 may be involved in processes related to cell wall dynamics, correlating its modifications with septum formation events would be particularly informative .

What are the optimal storage conditions for maintaining SPCC569.07 antibody activity?

To maximize the shelf-life and activity of SPCC569.07 antibodies, follow these storage recommendations:

• Short-term storage (up to 1 month):

  • Store at 4°C with preservative (0.02-0.09% sodium azide)

  • Avoid repeated freeze-thaw cycles

  • Aliquot working dilutions to minimize handling of stock

• Long-term storage (months to years):

  • Store at -20°C in small aliquots (10-50 μl)

  • Include cryoprotectants (40-50% glycerol) for freeze-thaw stability

  • For purified IgG preparations, maintain at 1.0 mg/ml concentration similar to other research antibodies

• Stability monitoring:

  • Periodically test antibody activity against known positive controls

  • Document lot numbers and performance characteristics

  • Include positive controls from previous lots when testing new preparations

• Shipping and handling considerations:

  • Transport on ice or with cold packs

  • Never freeze monoclonal antibody solutions during transport

  • Allow solutions to equilibrate to room temperature before opening to prevent condensation

• Recommended storage buffer composition:

  • Phosphate buffered saline (pH 7.4)

  • 0.09% sodium azide as preservative

  • Optional: 40-50% glycerol for frozen storage

  • Carrier protein (0.1-1% BSA) for dilute solutions

Always check for precipitate before use; if present, centrifuge the antibody solution before use rather than discarding it, as recommended for similar research antibodies .

How can I validate the specificity of SPCC569.07 antibodies in my experimental system?

Comprehensive validation of SPCC569.07 antibody specificity requires multiple complementary approaches:

• Genetic validation:

  • Test reactivity in wild-type versus SPCC569.07 deletion strains

  • Use strains with tagged versions (GFP-SPCC569.07) and detect with both anti-tag and anti-SPCC569.07 antibodies

  • Test in overexpression systems with controlled induction

• Biochemical validation:

  • Perform peptide competition assays using the immunizing peptide

  • Pre-absorb antibody with recombinant SPCC569.07 protein

  • Compare multiple antibodies targeting different epitopes of the same protein

• Cross-reactivity assessment:

  • Test against closely related proteins identified by sequence homology

  • Check reactivity in other yeast species (S. cerevisiae, C. albicans)

  • Analyze potential cross-reactivity with human proteins if planning mammalian studies

• Application-specific validation:

  • For Western blotting: Confirm expected molecular weight and specific band pattern

  • For immunoprecipitation: Verify enrichment by mass spectrometry

  • For immunofluorescence: Compare with localization of GFP-tagged protein

  • For flow cytometry: Use appropriate negative controls and blocking strategies

• Documentation of validation results:

Comprehensive validation ensures experimental reproducibility and confidence in research findings, particularly for studying novel or less-characterized proteins like SPCC569.07.

What cross-reactivity considerations should I be aware of when using SPCC569.07 antibodies?

Understanding potential cross-reactivity is essential for accurate interpretation of results with SPCC569.07 antibodies:

• Homologous proteins in S. pombe:

  • Identify proteins with sequence similarity using bioinformatics tools

  • Test antibody reactivity against purified recombinant proteins

  • Compare reactivity patterns in wild-type versus gene deletion strains

• Species cross-reactivity considerations:

  • S. pombe-specific antibodies may not recognize homologs in other organisms

  • Similar to how some antibodies (e.g., MA1-10866) show species-specific reactivity, SPCC569.07 antibodies may recognize proteins in closely related yeasts but not in more distant species

  • Test with recombinant proteins from various species before cross-species applications

• Detection of protein isoforms:

  • Alternative splicing or post-translational processing may generate multiple forms

  • Verify which isoforms are recognized by the antibody

  • Map epitope location relative to known protein domains and processing sites

• Technical aspects affecting apparent cross-reactivity:

  • Protein denaturation state can significantly affect epitope accessibility

  • Test both reducing and non-reducing conditions, as seen with other antibodies

  • Cell lysis conditions may release cross-reactive proteins normally segregated in different compartments

• Reducing unwanted cross-reactivity:

  • Increase washing stringency (higher salt concentration, longer washes)

  • Pre-absorb antibodies with lysates from deletion strains

  • Use more dilute antibody concentrations

  • Perform affinity purification against recombinant target protein

When working with antibodies targeting yeast proteins, it's especially important to verify species specificity, as evolutionary conservation varies significantly across protein families.

How can I quantitatively analyze SPCC569.07 expression using antibody-based methods?

For precise quantitative analysis of SPCC569.07 expression levels, implement these methodological approaches:

• Western blot-based quantification:

  • Use fluorescently-labeled secondary antibodies instead of chemiluminescence

  • Include a dilution series of recombinant protein for standard curve generation

  • Normalize to loading controls (tubulin, actin) using dual-color detection

  • Use imaging systems with wide linear dynamic range

  • Apply statistical analysis across multiple biological replicates

• ELISA-based quantification:

  • Develop sandwich ELISA using antibodies targeting different epitopes

  • Create a standard curve using purified recombinant SPCC569.07

  • Optimize sample dilution to ensure measurements in the linear range

  • Include spike-in controls to account for matrix effects

• Flow cytometry quantification:

  • For intracellular staining, optimize fixation and permeabilization conditions

  • Use calibration beads to convert fluorescence intensity to molecules of equivalent soluble fluorochrome (MESF)

  • Compare with GFP-tagged versions for validation

  • Apply dilutions between 1:50 to 1:100 as recommended for flow cytometry applications with similar antibodies

• Tissue/cell-type specific analysis:

  • Immunohistochemistry with digital image analysis

  • Measure staining intensity relative to calibrated standards

  • Account for background autofluorescence with appropriate controls

• Relative quantification across experimental conditions:

When comparing expression across different cellular compartments, ensure that extraction methods efficiently recover protein from all relevant structures, particularly for proteins potentially associated with the cell wall or membranes .

How can SPCC569.07 antibodies be used to study protein-glycosylation relationships in S. pombe?

SPCC569.07 antibodies provide valuable tools for investigating protein glycosylation in S. pombe, particularly given the importance of glycosylation in cell wall integrity and protein function:

• Glycosylation site mapping:

  • Immunoprecipitate SPCC569.07 using specific antibodies

  • Analyze glycosylation by mass spectrometry

  • Compare glycan profiles before and after treatment with specific glycosidases

  • Correlate with predicted glycosylation sites from sequence analysis

• Glycosylation mutant analysis:

  • Compare SPCC569.07 molecular weight and mobility in wild-type versus glycosylation pathway mutants

  • Use antibodies to assess protein stability and localization when glycosylation is impaired

  • Similar to studies of O-mannosylation mutants described in the literature , analyze SPCC569.07 in various glycosylation-defective backgrounds

• Functional impact assessment:

  • Correlate changes in glycosylation with protein function

  • Use site-directed mutagenesis to eliminate specific glycosylation sites

  • Monitor protein-protein interactions with and without proper glycosylation

• Glycosylation dynamics during cell cycle:

  • Synchronize cells and analyze glycosylation patterns at different stages

  • Focus particularly on septum formation and cell division, where glycoproteins play critical roles

  • Correlate with changes in cell wall composition and morphology

• Co-localization with glycosylation machinery:

  • Perform double immunofluorescence with SPCC569.07 antibodies and markers for glycosylation organelles

  • Track protein trafficking through the secretory pathway

  • Analyze residence time in glycosylation-competent compartments

Since S. pombe has well-characterized pathways for both N-linked and O-linked glycosylation , SPCC569.07 antibodies can help establish connections between these processes and specific protein functions.

How should I design experiments to study SPCC569.07 localization during cell division and septum formation?

For comprehensive analysis of SPCC569.07 dynamics during cell division, implement this experimental design:

• Time-course imaging strategy:

  • Synchronize cells using temperature-sensitive cdc mutants or other methods

  • Collect samples at defined intervals (5-10 minute increments)

  • Perform immunofluorescence with SPCC569.07 antibodies

  • Co-stain for septum (Calcofluor White), nucleus (DAPI), and cell cycle markers

• Multi-color co-localization analysis:

  • Combine SPCC569.07 antibody staining with markers for:

    • Septum initiation site (anillin/Mid1p)

    • Actomyosin ring (myosin/Myo2p)

    • Septum synthesis enzymes (glucan synthases)

    • Membrane trafficking machinery (exocyst components)

  • Perform high-resolution confocal or structured illumination microscopy

• Correlation with septum assembly events:

  • The S. pombe septum has distinct layers and assembly phases

  • Determine if SPCC569.07 associates with primary or secondary septum formation

  • Analyze co-localization with specific septum components using line-scan intensity profiles

• Mutant background analysis:

  • Examine SPCC569.07 localization in septation mutants

  • Test dependence on other factors by using temperature-sensitive alleles

  • Analyze effects of cytoskeleton disruption on SPCC569.07 recruitment

• Live-cell imaging validation:

  • Compare fixed-cell antibody staining with live imaging of GFP-tagged SPCC569.07

  • Perform FRAP (Fluorescence Recovery After Photobleaching) to measure protein dynamics

  • Use photoactivatable or photoswitchable tags to track specific protein populations

Given S. pombe's well-characterized septation process , this comprehensive approach will reveal SPCC569.07's specific role during cell division.

What are the best approaches for using SPCC569.07 antibodies in chromatin immunoprecipitation experiments?

If SPCC569.07 has potential nuclear functions or chromatin associations, these optimized ChIP protocols should be considered:

• Crosslinking optimization:

  • Test different formaldehyde concentrations (0.5-3%)

  • Optimize crosslinking times (5-30 minutes)

  • For challenging epitopes, try alternative crosslinking agents (DSG, EGS)

  • Include glycine quenching controls

• Chromatin fragmentation:

  • For S. pombe, optimize sonication conditions for 200-500 bp fragments

  • Verify fragmentation efficiency by gel electrophoresis

  • Consider enzymatic fragmentation (MNase) for nucleosome-resolution studies

  • Monitor chromatin solubilization efficiency

• Immunoprecipitation strategy:

  • Pre-clear chromatin with protein A/G beads

  • Compare different antibody amounts (2-10 μg per reaction)

  • Include appropriate controls (non-specific IgG, input samples)

  • For low abundance targets, increase starting material and optimize IP conditions

• Washing stringency:

  • Test washing buffers with increasing salt concentrations

  • Optimize detergent type and concentration

  • Balance between reducing background and maintaining signal

  • Include spike-in controls to normalize between samples

• Detection and analysis methods:

For proteins not previously characterized as DNA-binding factors, validate ChIP results with orthogonal methods such as DamID or FAIRE to confirm chromatin association.

How can I use SPCC569.07 antibodies to investigate stress responses in S. pombe?

To investigate SPCC569.07's role in stress responses, implement these antibody-based experimental approaches:

• Stress induction and time-course analysis:

  • Expose S. pombe cultures to various stressors (oxidative, heat, osmotic, cell wall)

  • Collect samples at multiple timepoints (0, 15, 30, 60, 120 minutes)

  • Analyze SPCC569.07 levels, modifications, and localization using specific antibodies

  • Compare with known stress response markers

• Post-translational modification changes:

  • Assess phosphorylation status using Phos-tag gels

  • Examine glycosylation changes with glycosidase treatments

  • Investigate ubiquitination and other modifications by immunoprecipitation

  • Correlate modifications with protein activity or localization

• Protein-protein interaction dynamics:

  • Perform co-immunoprecipitation under normal versus stress conditions

  • Identify stress-specific interaction partners

  • Validate interactions with proximity ligation assays

  • Map domains responsible for stress-dependent interactions

• Translocation and compartmentalization:

  • Use subcellular fractionation and immunoblotting

  • Perform immunofluorescence microscopy before and after stress

  • Quantify changes in localization patterns

  • Correlate with cellular structures affected by specific stressors

• Quantitative stress response profiling:

Since cell wall integrity is a key aspect of yeast stress responses, and given the potential relationship of SPCC569.07 to cell wall processes , focusing on cell wall stressors may be particularly informative.

How can SPCC569.07 antibodies be combined with proximity labeling techniques for proteomic analyses?

Integrating SPCC569.07 antibodies with proximity labeling offers powerful approaches for mapping protein interaction networks:

• Antibody-based BioID applications:

  • Immunoprecipitate SPCC569.07 and associated complexes

  • Conjugate purified complexes with BioID enzyme

  • Perform proximity labeling in vitro

  • Identify labeled proteins by mass spectrometry

  • Compare interactome across different conditions

• Split-BioID validation systems:

  • Generate fusion proteins with SPCC569.07 and split-BioID components

  • Validate antibody-detected interactions

  • Map spatial organization of protein complexes

  • Identify transient interactions missed by conventional methods

• Antibody-guided APEX2 labeling:

  • Use SPCC569.07 antibodies for immunofluorescence to confirm APEX2 fusion localization

  • Perform temporal control of labeling with H₂O₂ pulses

  • Compare spatial distribution of interaction partners with antibody staining patterns

  • Correlate with functional studies in various genetic backgrounds

• Quantitative interactome profiling:

  • Combine antibody pulldown with SILAC or TMT labeling

  • Identify condition-dependent interactions

  • Perform network analysis of protein complexes

  • Validate key interactions with traditional biochemical approaches

• Methodological considerations for yeast applications:

These approaches can reveal SPCC569.07's functional networks in processes like cell wall biogenesis, stress response, and cell division, providing insights beyond traditional antibody applications.

What considerations are important when designing super-resolution microscopy experiments with SPCC569.07 antibodies?

For optimal super-resolution imaging of SPCC569.07 localization, implement these specialized protocols:

• Sample preparation optimization:

  • Test multiple fixation methods (formaldehyde, methanol, combined approaches)

  • Optimize cell wall digestion for balanced epitope preservation and antibody access

  • Use small F(ab) fragments for improved penetration and reduced linkage error

  • Consider expansion microscopy for physically enlarged samples

• Fluorophore selection for different super-resolution techniques:

  • STED: Atto647N, Star635P (photostable, high brightness)

  • STORM/PALM: Alexa Fluor 647, mEos (photoswitchable)

  • SIM: Alexa Fluor 488, DyLight 550 (bright, minimal bleaching)

  • Test secondary antibody conjugates for optimal performance

• Multi-color imaging strategies:

  • Use spectrally separated fluorophores to minimize bleed-through

  • Include fiducial markers for channel alignment

  • Perform sequential imaging for challenging combinations

  • Design controls for chromatic aberration correction

• Resolution-enhancing approaches:

  • Primary antibody direct labeling to minimize displacement error

  • Use monovalent detection systems (Fab fragments, nanobodies)

  • Implement cross-correlation analysis for co-localization studies

  • Apply deconvolution algorithms appropriate for each technique

• Quantitative analysis methods:

When imaging septum-associated proteins in S. pombe, focus particularly on the three-dimensional organization at the division site, as the septum has complex layered architecture with distinct protein compositions .

How can I use SPCC569.07 antibodies to investigate protein degradation pathways?

For comprehensive analysis of SPCC569.07 degradation mechanisms, implement these antibody-based strategies:

• Half-life determination approaches:

  • Cycloheximide chase with antibody detection at multiple timepoints

  • Pulse-chase labeling combined with immunoprecipitation

  • Quantitative Western blotting with normalization to stable proteins

  • Compare degradation kinetics across growth conditions and genetic backgrounds

• Degradation pathway identification:

  • Treat cells with specific inhibitors:

    • Proteasome (MG132, bortezomib)

    • Autophagy (3-methyladenine, bafilomycin A1)

    • Vacuolar proteases (PMSF, pepstatin A)

  • Use immunoblotting to detect stabilization and intermediate degradation products

  • Combine with genetic approaches using pathway mutants

• Ubiquitination analysis:

  • Immunoprecipitate SPCC569.07 under denaturing conditions

  • Probe with anti-ubiquitin antibodies

  • Alternatively, pull down ubiquitinated proteins and probe for SPCC569.07

  • Map ubiquitination sites by mass spectrometry

• Autophagy/vacuolar targeting:

  • Co-localization of SPCC569.07 with autophagy markers (Atg8)

  • Track degradation during nitrogen starvation (autophagy-inducing condition)

  • Analyze protein fragments in vacuolar preparations

  • Correlate with known autophagy substrates

• Conditional degradation analysis:

Understanding SPCC569.07 turnover may provide insights into its regulation during stress responses and cell cycle progression, particularly if it's involved in dynamic processes like cell wall remodeling during growth and division .